Abstract:Background: Human microbial communities play an important role in some physiological process of human beings. Nevertheless, the identification of microbe-disease associations through biological experiments is costly and time-consuming. Hence, the development of calculation models is meaningful to infer latent associations between microbes and diseases. Aims: In this manuscript, we aim to design a computational model based on the Graph Convolutional Neural Network with Multi-layer Attention mechanism, called GCNMA, to infer latent microbe-disease associations. objective: In this paper, we proposed a novel computational model based on the Graph Convolutional Neural Network with Multi-layer Attention mechanism, called GCNMA, to detect potential microbe-disease associations. Objective: This study aims to propose a novel computational model based on the Graph Convolutional Neural Network with Multi-layer Attention mechanism, called GCNMA, to detect potential microbe-disease associations. Method: In GCNMA, the known microbe-disease association network was first integrated with the microbe-microbe similarity network and the disease-disease similarity network into a heterogeneous network first. Subsequently, the graph convolutional neural network was implemented to extract embedding features of each layer for microbes and diseases respectively. Thereafter, these embedding features of each layer were fused together by adopting the multi-layer attention mechanism derived from the graph convolutional neural network, based on which, a bilinear decoder would be further utilized to infer possible associations between microbes and diseases. Result: Finally, to evaluate the predictive ability of GCNMA, intensive experiments were done and compared results with eight state-of-the-art methods which demonstrated that under the frameworks of both 2-fold cross-validations and 5-fold cross-validations, GCNMA can achieve satisfactory prediction performance based on different databases including HMDAD and Disbiome simultaneously. Moreover, case studies on three kinds of common diseases such as asthma, type 2 diabetes, and inflammatory bowel disease verified the effectiveness of GCNMA as well. Conclusion: GCNMA outperformed 8 state-of-the-art competitive methods based on the benchmarks of both HMDAD and Disbiome. other: no

PM-CNN: microbiome status recognition and disease detection model based on phylogeny and multi-path neural network

PMINR: Pointwise Mutual Information-Based Network Regression – with Application to Studies of Lung Cancer and Alzheimer’s Disease

Multimodal deep learning applied to classify healthy and disease states of human microbiome

Graph Convolutional Neural Network with Multi-Layer Attention Mechanism for Predicting Potential Microbe-Disease Associations

MetaNN: accurate classification of host phenotypes from metagenomic data using neural networks

MVGCNMDA: Multi-view Graph Augmentation Convolutional Network for Uncovering Disease-Related Microbes

Faecal microbiome-based machine learning for multi-class disease diagnosis

A permutable MLP-like architecture for disease prediction from gut metagenomic data

Gut metagenome-derived image augmentation and deep learning improve prediction accuracy of metabolic disease classification

GCNPMDA: Human microbe-disease association prediction by hierarchical graph convolutional network with layer attention

A Dirichlet-Multinomial Bayes Classifier for Disease Diagnosis with Microbial Compositions

MKMR: a multi-kernel machine regression model to predict health outcomes using human microbiome data

Multitask Knowledge-primed Neural Network for Predicting Missing Metadata and Host Phenotype based on Human Microbiome

Towards multi-label classification: Next step of machine learning for microbiome research

DeepMicro: Deep Representation Learning for Disease Prediction Based on Microbiome Data

Image and graph convolution networks improve microbiome-based machine learning accuracy

A novel deep learning method for predictive modeling of microbiome data

GCSENet: A GCN, CNN and SENet ensemble model for microRNA-disease association prediction

Improving the identification of miRNA–disease associations with multi-task learning on gene–disease networks

DCMD: Distance-based Classification Using Mixture Distributions on Microbiome Data

MegaD: Deep Learning for Rapid and Accurate Disease Status Prediction of Metagenomic Samples